ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2179

Erosive Hand Osteoarthritis, Metabolic Syndrome and Knee Osteoarthritis: A Cross-sectional Study Using Data from the PROCOAC Cohort

Natividad Oreiro1, Ignacio Rego-Pérez 1, Maria T. Silva 1, Sara Relaño 1, Mercedes Fernandez-Moreno 2, Paula Ramos-Louro 1, Alejandro Duran-Sotuela 1, Sonia Pertega 3 and Francisco J. Blanco 1, 1Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España, A Coruña, Spain, 2Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España. CIBER-BBM, A Coruña, Spain, 3Unidad de Epidemiología Clínica y Bioestadística. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España, A Coruña, Spain

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: erosive, hand and metabolic syndrome, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoarthritis – Clinical Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Erosive hand osteoarthritis (EOA) is often considered a more severe form of hand OA. However, more data are needed regarding this phenotype to conclude if represents a different subset of hand OA or a different degree of affectation of the same disease. The purpose of this work is to compare the clinical pattern of patients with EOA with those that do not show this phenotype

Methods: This cross-sectional study was conducted in the Prospective Cohort of Osteoarthritis A Coruna (PROCOAC). The cohort consists of 1136 subjects, of which 877 were diagnosed of hand OA following ACR criteria. After reviewing the x-rays, we split the cohort into patients with and without EOA, and subsequently analyzed both clinical and demographic data within each group, together with the assessment of the AUStralian CANadian Osteoarthritis Hand (AUSCAN) index. The study consisted in a Univariate analysis comparing different variables between both groups, followed by a stepwise regression logistic regression analysis.

Results: The mean age of the cohort was 63.61±9.03 years and consisted of 718 females and 159 males. Of the 877 OA patients, 167 had EOA. The

Univariate analysis revealed that patients with EOA were younger (59.85±7.95 vs 64.43±9.04;p< 0.001), smokers (p=0.008), with lower BMI (p=0.007), increased inflammatory episodes (p< 0.001), more presence of nodal OA (p=0.001), with family history or suffering psoriasis (p=0.046) and less number of damaged joints (p< 0.001), specially the knee (p< 0.001). In addition, despite the higher number of females suffering from hand OA, no significant differences between erosive and non-erosive phenotypes in terms of gender were detected.
The regression model (Table 1) confirmed the strong association of age (OR=0.964;95%CI=0.939-0.991;p=0.008), inflammatory episodes (OR=4.367;95%CI=2.489-7.663;p< 0.001) and increased prevalence of nodal OA (OR=2.249;95%CI=1.159-4.363;p=0.017) with the EOA. Interestingly, the model also showed MetS as a risk factor too, specifically over 64 years (OR=2.194;95%CI=1.249-3.854;p=0.006), with the tryglicerides content as the metabolic component most involved in this association (p=0.082). In addition, EOA patients show a lower prevalence of knee OA (OR=0.437;95%CI=0.259-0.739;p=0.002) and to carry this phenotype at baseline does not confer a significant increased risk for radiographic knee OA progression over time (p=0.515). The AUSCAN score showed significantly higher mean values in patients with the EOA: pain (58.66±28.78 vs 41.83±32.26; p< 0.001), function (56.19±27.44 vs 39.22±30.01; p< 0.001) and stiffness (55.47±32.34 vs 39.28±36.41;p=0.001).

Conclusion: EOA is associated with more inflammation in younger patients, and worst AUSCAN score. Contrarily to the non-erosive phenotype, the presence of erosions associates with a lower occurrence of other forms of OA, specially knee OA, as well as with no incidence on the radiographic knee OA progression. In our cohort, EOA seems to be more localized in the hand and it also seems to be associated with psoriasis and nodal OA.


Tabla1


Disclosure: N. Oreiro, None; I. Rego-Pérez, None; M. Silva, None; S. Relaño, None; M. Fernandez-Moreno, None; P. Ramos-Louro, None; A. Duran-Sotuela, None; S. Pertega, None; F. Blanco, None.

To cite this abstract in AMA style:

Oreiro N, Rego-Pérez I, Silva M, Relaño S, Fernandez-Moreno M, Ramos-Louro P, Duran-Sotuela A, Pertega S, Blanco F. Erosive Hand Osteoarthritis, Metabolic Syndrome and Knee Osteoarthritis: A Cross-sectional Study Using Data from the PROCOAC Cohort [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/erosive-hand-osteoarthritis-metabolic-syndrome-and-knee-osteoarthritis-a-cross-sectional-study-using-data-from-the-procoac-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/erosive-hand-osteoarthritis-metabolic-syndrome-and-knee-osteoarthritis-a-cross-sectional-study-using-data-from-the-procoac-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology